Global Kidney Cancer Therapeutics & Diagnostics Market Growth, Share, Size, Trends and Forecast (2023 - 2029)

Segmented by Cancer Type;

Clear cell RCC, Papillary RCC, Chromophobe RCC, Urothelial carcinoma/Transitional cell carcinoma, Other Kidney cancers (Wilms tumor, Renal sarcoma and Collecting duct RCC).

Segmented by Component;

Drugs - Therapeutic Class[Targeted Therapy, Immunotherapy and Other Therapeutic Class], - By Pharmacologic Class[Angiogenesis Inhibitors, Monoclonal Antibodies, mTOR Inhibitors and Cytokine Immunotherapy (IL-2)], - Diagnostics[Biopsy, Imaging Tests, Blood Tests and Other Diagnostics].

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2019 - 2029).
Report ID: Rn979530336 Published Date: January, 2023 Updated Date: February, 2023

Introduction

Global Kidney Cancer Therapeutics & Diagnostics Market (USD Million), 2019 - 2029

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2019 - 2029
2019 105.0
2020 118.1
2021 135.9
2022 143.2
2023 147.9
2024 155.3
2025 174.3
2026 176.6
2027 181.9
2028 190.0
2029 220.1

In the year 2022, the Global Kidney Cancer Therapeutics & Diagnostics Market was valued at USD 6,344.95 million. The size of this market is expected to increase to USD 14,291.79 million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of 12.3%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Cancer Type
    2. Market Snapshot, By Component
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Kidney Cancer Therapeutics & Diagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Kidney Cancer
        2. Increased R&D Expenditure of Pharmaceutical Companies
      2. Restraints
        1. High Cost Associated with Treatment
        2. Low Success Rate in Clinical Trials for Cancer Drugs
        3. Regulatory Issues
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Kidney Cancer Therapeutics & Diagnostics Market, By Cancer Type, 2021 - 2031 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2023 and 2029 (%)
      3. Y-o-Y Growth Analysis, 2020 - 2029
      4. Segment Trends
        1. Clear cell RCC
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
        2. Papillary RCC
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
        3. Chromophobe RCC
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
        4. Urothelial carcinoma/Transitional cell carcinoma
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
        5. Other Kidney cancers (Wilms tumor, Renal sarcoma, Collecting duct RCC)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
    2. Global Kidney Cancer Therapeutics & Diagnostics Market, By Component, 2021 - 2031 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2023 and 2029 (%)
      3. Y-o-Y Growth Analysis, 2020 - 2029
      4. Segment Trends
        1. Drugs
          1. Introduction
          2. Market Share Analysis, 2023 and 2029 (%)
          3. Y-o-Y Growth Analysis, 2020 - 2029
          4. Segment Trends
            1. Therapeutic Class
              1. Introduction
              2. Market Share Analysis, 2023 and 2029 (%)
              3. Y-o-Y Growth Analysis, 2020 - 2029
              4. Segment Trends
                1. Targeted Therapy
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                2. Immunotherapy
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                3. Other Therapeutic Class
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
            2. By Pharmacologic Class
              1. Introduction
              2. Market Share Analysis, 2023 and 2029 (%)
              3. Y-o-Y Growth Analysis, 2020 - 2029
              4. Segment Trends
                1. Angiogenesis Inhibitors
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                2. Monoclonal Antibodies
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                3. mTOR Inhibitors
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                4. Cytokine Immunotherapy (IL-2)
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
            3. Diagnostics
              1. Introduction
              2. Market Share Analysis, 2023 and 2029 (%)
              3. Y-o-Y Growth Analysis, 2020 - 2029
              4. Segment Trends
                1. Biopsy
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                2. Imaging Tests
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                3. Blood Tests
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
                4. Other Diagnostics
                  1. Introduction
                  2. Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
    3. Global Kidney Cancer Therapeutics & Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2023 and 2029 (%)
      3. Y-o-Y Growth Analysis, 2020 - 2029
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2029 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2029 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Amgen Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Bayer AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. F. Hoffmann-La Roche
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. ABBOTT LABORATORIES
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. BRISTOL-MYERS SQUIBB COMPANY
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare In Vitro Diagnostics Kidney Renal Function Test
Global Kidney Renal Function Test Market Growth, Share, Size, Trends and Forecast (2023 - 2029)

In the year 2022, the Global Kidney Renal Function Test Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Kidney Stone Retrieval Devices
Global Kidney Stone Retrieval Devices Market Growth, Share, Size, Trends and Forecast (2023 - 2029)

In the year 2022, the Global Kidney Stone Retrieval Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Kidney Stones Management Devices
Global Kidney Stones Management Devices Market Growth, Share, Size, Trends and Forecast (2023 - 2029)

In the year 2022, the Global Kidney Stones Management Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Kinase Inhibitors
Global Kinase Inhibitors Market Growth, Share, Size, Trends and Forecast (2023 - 2029)

In the year 2022, the Global Kinase Inhibitors Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...